trending Market Intelligence /marketintelligence/en/news-insights/trending/6ueb8y2sansqufwdyoawrq2 content esgSubNav
In This List

Epizyme appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Epizyme appoints board member

Epizyme Inc. appointed Michael Giordano to the board.

Most recently, Giordano was senior vice president and head of development of oncology and immuno-oncology for Bristol-Myers Squibb Co.